其他品牌 品牌
代理商厂商性质
广州市所在地
马泰勒虫免疫荧光玻片
theileria equi IFA Substrate slide
广州健仑生物科技有限公司
主要用途:用于检测马血清中的马泰勒虫IgG/IgM抗体
产品规格:12 孔/张,10 张/盒
主要产品包括:包柔氏螺旋体菌、布鲁氏菌、贝纳特氏立克次体、土伦杆菌、钩端螺旋体、新型立克次体、恙虫病、立克次体、果氏巴贝西虫、马焦虫、牛焦虫、利什曼虫、新包虫、弓形虫、猫流感病毒、猫冠状病毒、猫疱疹病毒、犬瘟病毒、犬细小病毒等病原微生物的 IFA、MIF、ELISA试剂。
马泰勒虫免疫荧光玻片
我司还提供其它进口或国产试剂盒:登革热、疟疾、西尼罗河、立克次体、无形体、蜱虫、恙虫、利什曼原虫、RK39、汉坦病毒、深林脑炎、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。
欢迎咨询
欢迎咨询2042552662
JL-FL54 | 牛双芽巴贝西虫免疫荧光玻片 | babesia bigemina IFA Substrate slide |
JL-FL55 | 牛双芽巴贝西虫免疫荧光试剂盒 | babesia bigemina IFA Kit |
JL-FL56 | 牛巴贝西虫免疫荧光玻片 | babesia bovis IFA Substrate slide |
JL-FL57 | 牛巴贝西虫免疫荧光试剂盒 | babesia bovis IFA Kit |
JL-FL58 | 驽巴贝西虫免疫荧光玻片 | babesia caballi IFA Substrate slide |
JL-FL59 | 驽巴贝西虫免疫荧光试剂盒 | babesia caballi IFA Kit |
JL-FL60 | theileria equi IFA Substrate slide | |
JL-FL61 | 马泰勒虫免疫荧光试剂盒 | theileria equi IFA Kit |
JL-FL62 | 利什曼虫IgG免疫荧光试剂盒 | Leishmania IgG IFA Kit |
JL-FL63 | 新孢子虫IgG免疫荧光试剂盒(检测狗) | Neospora caninum IgG IFA Kit |
JL-FL64 | 新孢子虫IgG免疫荧光试剂盒(检测马) | Neospora caninum IgG IFA Kit |
JL-FL65 | 猫杯状病毒IgG免疫荧光玻片 | Feline Calicivirus IgG IFA Substrate slide |
JL-FL66 | 猫冠状病毒IgG免疫荧光玻片 | Feline Coronavirus IgG IFA Substrate slide |
JL-FL67 | 猫疱疹病毒IgG免疫荧光玻片 | Feline Herpesvirus IgG IFA Substrate slide |
JL-FL68 | 犬瘟病毒IgG免疫荧光玻片 | Canine Distemper IgG IFA Substrate slide |
JL-FL69 | 犬细小病毒IgG免疫荧光玻片 | Canine Parvovirus IgG IFA Substrate slide |
二维码扫一扫
【公司名称】 广州健仑生物科技有限公司
【】 杨永汉
【】
【腾讯 】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化】
但是,Raz及其同事们发现,TPRV1也在肠道上皮细胞表达,在那里它被表皮生长因子受体(EGFR)激活。EGFR是肠道中细胞增殖的一个重要驱动力,大约每四到六天,肠道上皮层就被替换。
本文*作者Petrus de Jong博士称:“保持肠道内正常细胞更新,需要一个基本水平的EGFR活性。然而,如果EGFR信号是无限制的,散发性肿瘤的发展风险就会增加。”
科学家们发现,一旦TRPV1被EGFR激活,可引发一种对EGFR的直接负反馈,从而抑制后者降低不必要的生长和肠道肿瘤发展风险。他们发现,缺乏TRPV1的转基因小鼠,肠道肿瘤的生长率高于正常。
de Jong称:“这些结果表明,上皮TRPV1通常作为肠道内的一个肿瘤抑制基因。”此外,zui近对人结肠直肠癌样本的分子研究,发现了TRPV1基因中的多个突变,然而Raz指出,目前还没有直接的证据表明,TRPV1缺陷是人类结直肠癌的危险因素。他说:“在今后的临床研究中,应该解决TRPV1功能和人结直肠癌之间的直接关联。”
但是,如果这是事实的话,当前的研究指出,一种潜在的治疗方法可能是辣椒素,它作为哺乳动物的一种刺激物,与组织接触产生一种灼热感。辣椒素已被广泛用作外用药膏的镇痛药,其性质是作为一种压倒神经的刺激物,使神经不能长时间的疼痛。它也是胡椒喷雾剂的活性成分。
研究人员给遗传上更倾向于患多种胃肠道肿瘤的小鼠喂食辣椒素。这种治疗方法导致肿瘤负担减少,使小鼠的寿命延长了超过30%。当联合塞来昔布(celecoxib,一种COX-2非甾体类抗炎药物,已被批准用于治疗一些形式的关节炎和疼痛)使用时,治疗更加有效。
在一个共同合作中,研究人员在纽约州立大学水牛城分校的莫成?帕特尔博士以及劳森健康研究院和加拿大西安大略大学的大卫?希尔博士的带领之下,评估粒线体中的综合酵素--丙酮酸脱氢酶复合体在小鼠新生期间如何调控胰岛的β细胞的发育和成熟。
However, Raz and colleagues found that TPRV1 is also expressed in intestinal epithelial cells, where it is activated by the epidermal growth factor receptor (EGFR). EGFR is an important driver of cell proliferation in the gut, and the gut epithelium is replaced every about four to six days.
"The maintenance of normal cell renewal in the intestine requires a basic level of EGFR activity, but if the EGFR signal is unrestricted, the risk of developing sporadic tumors is increased," said lead author Petrus de Jong.
Scientists have found that once TRPV1 is activated by EGFR, it can trigger a direct negative feedback on EGFR, thereby inhibiting the latter from reducing the risk of unnecessary growth and intestinal tumor development. They found that, in the absence of TRPV1 transgenic mice, the growth rate of intestinal tumors was higher than normal.
"These results show that epithelial TRPV1 is often used as a tumor suppressor in the gut." In addition, a recent molecular study of human colorectal cancer samples revealed multiple mutations in the TRPV1 gene, de Jong said. However, Raz noted that at present There is no direct evidence that TRPV1 deficiency is a risk factor for human colorectal cancer. He said: "In future clinical studies, a direct link between TRPV1 function and human colorectal cancer should be addressed."
However, if this is true, current research suggests that one potential treatment may be capsaicin, a stimulant of mammals that comes into contact with the tissue to create a burning sensation. Capsaicin has been widely used as an analgesic for topical ointments, which act as an overwhelming stimulant that prevents the nerves from prolonged pain. It is also the active ingredient of pepper spray.
Researchers fed caprine to mice genetically more prone to multiple gastrointestinal tumors. This treatment led to reduced tumor burden, extending the lifespan of mice by more than 30%. The treatment is more effective when used in combination with celecoxib (a COX-2 NSAID that has been approved for the treatment of some forms of arthritis and pain).
In a joint effort, researchers under the leadership of Dr. Mo Cheng Pa, of the State University of New York at Buffalo, and Dr. David Hill of the Lawson Health Institute and the University of Western Ontario in Canada, In the synthesis of enzymes - pyruvate dehydrogenase complex in mouse neonatal period how the regulation of islet β cell development and maturation.